Exactech News (NASDAQ:EXAC)

DateTimeSource
Headline
12/07/20174:30PMBWExactech Announces Successful First Surgery with Vantage ® Total Ankle Mobile Bearing System
Professor Victor Valderrabano, MD, PhD, completes first global case Exactech, Inc. (Nasdaq:EXAC), a developer and producer of bone and joint restoration products for extremities, hip, and knee, announced today the successful first surgery using its new Vantage® Total Ankle Mobile Bearing System, the newest addition to... More...>>
12/04/20178:00AMBWExactech and TPG Capital Announce Amended Merger Agreement Providing for Increase in Merger Consideration to $49.25 per share
Merger with TPG Capital Now Valued at $737 Million Exactech, Inc. (Nasdaq: EXAC), a leading developer and producer of orthopaedic implant devices and surgical instrumentation for extremities and large joints, announced today that it has entered into an amendment to its merger agreement with TPG Capital and certain of its... More...>>
11/01/20171:15PMBWExactech Announces Successful First Revision Knee Replacement Surgery with Truliant® Instrumentation
System to Debut at the AAHKS Annual Meeting, Booth #908 in Dallas Exactech (Nasdaq: EXAC), a developer and producer of bone and joint restoration products and biologic solutions for extremities, knee and hip, is pleased to announce that the first revision knee surgery was performed using the company's award-winning Truliant®... More...>>
10/30/20174:05PMBWExactech Q3 Revenue $61.4 Million
Q3 Net Income $2.9 Million; Diluted EPS $0.20 Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products and biologic solutions for extremities, knee and hip, announced today that revenue for the third quarter of 2017 increased 2% to $61.4 million from $59.9 million in the third quarter... More...>>
10/26/201712:33PMPRNUSSHAREHOLDER ALERT: Monteverde & Associates PC Announces An Investigation Of Exactech, Inc. - EXAC
SHAREHOLDER ALERT: Monteverde & Associates PC Announces An Investigation Of Exactech, Inc. - EXAC PR Newswire NEW YORK, Oct. 26, 2017 NEW YORK, Oct. 26, 2017 /PRNewswire/ -- Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a boutique securities firm headquartered at the Empire State... More...>>
10/25/20174:05PMBWExactech Cancels Q3 Earnings Call Previously Scheduled for Tuesday, October 31, 2017
Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products and biologic solutions for extremities, knee and hip, announced today that, due to its definitive agreement with TPG Capital to go private, the company will not hold the Third Quarter conference call previously scheduled for... More...>>
10/24/20176:54PMPRNUSWEISSLAW LLP: Exactech, Inc. Acquisition May Not Be in the Best Interests of EXAC Shareholders
WEISSLAW LLP: Exactech, Inc. Acquisition May Not Be in the Best Interests of EXAC Shareholders PR Newswire NEW YORK, Oct. 24, 2017 NEW YORK, Oct. 24, 2017 /PRNewswire/ -- WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the Board of Directors of Exactech, Inc. ("EXAC" or... More...>>
10/24/20178:00AMPRNUSALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Exactech
ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Exactech PR Newswire NEW YORK, Oct. 24, 2017 NEW YORK, Oct. 24, 2017 /PRNewswire/ -- Rowley Law PLLC is investigating potential claims against Exactech (NASDAQ: EXAC) and its board of directors for breach of fiduciary duty concerning the proposed acquisition... More...>>
10/23/20175:24PMPRNUSHarwood Feffer LLP Announces Investigation of Exactech, Inc.
Harwood Feffer LLP Announces Investigation of Exactech, Inc. PR Newswire NEW YORK, Oct. 23, 2017 NEW YORK, Oct. 23, 2017 /PRNewswire/ -- Harwood Feffer LLP (www.hfesq.com) is investigating potential claims against the board of directors of Exactech, Inc. ("Exactech" or the "Company") (NASDAQ: EXAC) concerning the proposed... More...>>
10/23/201710:01AMPRNUSExactech (EXAC) Alert: Johnson Fistel Investigates Proposed Sale of Exactech, Inc.; Is $42 A Fair Price?
Exactech (EXAC) Alert: Johnson Fistel Investigates Proposed Sale of Exactech, Inc.; Is $42 A Fair Price? PR Newswire SAN DIEGO, Oct. 23, 2017 SAN DIEGO, Oct. 23, 2017 /PRNewswire/ -- Shareholder rights law firm Johnson Fistel, LLP has launched an investigation into whether the board members of Exactech, Inc. (NASDAQ: EXAC... More...>>
10/23/20178:15AMBWExactech Enters Definitive Agreement with TPG Capital to Go Private
Leading Healthcare Investor Provides Company with Strategic Growth Capital Exactech Shareholders To Receive $42.00 Per Share In Cash Transaction Values Exactech at $625 Million Represents a Premium of Approximately 31% to the Prior Closing and a 37% Premium to the 90-day Volume Weighted Average Price Exactech (Nasdaq:... More...>>
10/12/20174:05PMBWExactech Comments on Impact of Hurricanes Irma and Harvey; Adjusts Q3 Earnings Guidance and Announces Q3 Earnings Call
Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products and biologic solutions for extremities, knee and hip, said today it is adjusting guidance for the third quarter of 2017 as a result of the impact of Hurricanes Irma and Harvey. CEO and President David Petty said the estimated... More...>>
09/05/201710:43AMBWExactech To Present to Investors at Baird 2017 Global Healthcare Conference
Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products and biologic solutions for extremities, knee and hip, will present to investors at the Baird 2017 Global Healthcare Conference in New York on Thursday, September 7, 2017. The company will also host one-on-one meetings with institutional... More...>>
08/21/201710:28AMBWExactech’s Truliant® Knee System Instrumentation Honored with International Design Excellence Award (IDEA®)
Exactech (Nasdaq:EXAC), a developer and producer of bone and joint restoration products and biologic solutions for extremities, knee and hip, announced today that the new Truliant® Knee System’s surgical instrumentation received a bronze award in the 2017 International Design Excellence Awards (IDEA®). Sponsored annually... More...>>
07/27/20174:30PMBWExactech Q2 Revenue $67.3 Million On Continuing Strong Extremities Revenue
Q2 Net Income $4.8 Million; Diluted EPS $0.33 Exactech, Inc. (Nasdaq:EXAC), a developer and producer of bone and joint restoration products and biologic solutions for extremities, knee and hip, announced today that revenue for the second quarter of 2017 increased 2% to $67.3 million from $66.1 million in the second quarter... More...>>
07/13/20175:36PMBWExactech Schedules Second Quarter 2017 Earnings Release and Conference Call
Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products and biologic materials for extremities, hip and knee will release its second quarter 2017 financial results on Thursday, July 27, 2017. A copy of the earnings release will be available at http://www.hawkassociates.com. The company... More...>>
06/29/20179:25AMBWExactech Introduces New Computer-Assisted Software Application for Simplified Guidance in Total Knee Replacement
Surgeon Reports Success with First Case Using ExactechGPS TKA PLUS Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products and biologic solutions for extremities, knee and hip, announced the introduction of ExactechGPS® TKA PLUS, a new software application that provides orthopaedic... More...>>
06/22/20179:15AMBWExactech Expands Presence in Japan with Newly Approved Shoulder, Knee and Hip Replacement Systems
Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products and biologic solutions for extremities, knee and hip, announced today that the company marked the first clinical use of recently approved shoulder, knee and hip replacement systems in Japan this quarter. These surgeries coincide... More...>>
06/12/201710:37AMBWAlteon® HA Femoral Hip Stem Rounds Out Big Week of First Surgeries for Exactech
Exactech (Nasdaq: EXAC), a developer and producer of bone and joint restoration products and biologic solutions for extremities, knee and hip, announced that the first surgeries using the new Alteon® HA Femoral Hip Stem took place last week. The total hip replacements were performed by implant design team members Joseph... More...>>
06/06/20178:30AMBWExactech Announces Successful First Surgeries with New Equinoxe® Preserve Stem and ExactechGPS® Shoulder Application
Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products and biologic solutions for extremities, knee and hip, announced today a successful first surgery using the new Equinoxe® Preserve stem, a conservative shoulder treatment option designed to preserve humeral bone in shoulder replacement... More...>>
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:32 V:us D:20171215 10:11:55